U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
Source: SeekingAlpha
2026-01-09 22:05:00 ET
Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings....
Read the full article on Seeking Alpha
For further details see:
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
Akoustis Technologies Inc.
NASDAQ: AKTS
AKTS Trading
1.33% G/L:
$19.48 Last:
108,590 Volume:
$19 Open:
AKTS Latest News
February 24, 2026 08:00:00 am
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
AKTS Stock Data
$997,718,904
32,721,380
0.16%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
